Private Equity

  • April 22, 2026

    4 Firms Build Amneal's Up To $1.1B Kashiv Biosimilars Buy

    Biopharmaceutical company Amneal Pharmaceuticals Inc. on Wednesday unveiled plans to acquire biosimilars-focused Kashiv BioSciences LLC in a deal worth up to $1.1 billion that was built by four law firms.

  • April 22, 2026

    Willkie Helps Mutares Raise €105M For US Expansion

    German private equity shop Mutares said Wednesday that it has raised €105 million ($123 million) to fuel its expansion in the U.S. through acquisitions.

  • April 21, 2026

    Armistice Capital Head Calls COVID Stock Rise 'Fun,' 'Lucky'

    Armistice Capital's founder defended his hedge fund Tuesday from claims it pump-and-dumped $250 million in Vaxart stock during the COVID-19 pandemic, telling a California federal jury that he and his fund got "lucky" and that the stock's rapid surge was "fun."

  • April 21, 2026

    Jury Told Ex-Finance CEO Is The Fall Guy In $100M Fraud Case

    Counsel for the founder of Beneficient on Tuesday told a Manhattan federal jury that the founder of the Dallas-based financial services firm did not defraud its onetime business partner GWG Holdings out of more than $100 million, saying a group of former insiders are trying to scapegoat the executive for GWG's downfall.

  • April 21, 2026

    Biotech Co. Investors Clash Over 'Self-Dealing' Claim

    Attorneys for a biopharmaceutical and technology company stockholder and a group of venture investors sharply disagreed Tuesday over whether a financing deal was a lifeline for a struggling company or a self-serving maneuver that enriched insiders, as they argued a motion to dismiss the derivative suit in the Delaware Chancery Court.

  • April 21, 2026

    Del. Supreme Court Upholds Ruling On Truth Social Shares

    The Delaware Supreme Court has affirmed a lower court ruling granting additional stock to the founding shareholder in the company that took President Donald Trump's Truth Social Media public, turning away a request from the shareholder for a second shot to prove it is owed even more shares.

  • April 21, 2026

    Buyer Sues PE Firm, Alleging Fraud In $26M Manufacturer Sale

    A Michigan-based buyer has sued a private equity firm and two executives in Delaware's Court of Chancery, accusing them of orchestrating a yearslong scheme to inflate a manufacturing company's value and fraudulently induce a $26 million sale.

  • April 21, 2026

    Latham, Loeb Guide AI Battery Co.'s $250M SPAC Merger

    Electra Vehicles Inc., a provider of artificial intelligence-driven battery technology that is represented by Latham & Watkins LLP, outlined Tuesday its plans to go public by merging with a special purpose acquisition company advised by Loeb & Loeb LLP, in a deal valued at more than $250 million.

  • April 21, 2026

    3 Firms Guide $1.2B Semiconductor Equipment SPAC Deal

    U.S.-based semiconductor materials company Forge Nano said Tuesday it has agreed to combine with blank check company Archimedes Tech SPAC Partners II Co. in a deal that values Forge Nano at $1.2 billion.

  • April 21, 2026

    HarbourVest Wraps 13th Fund With $2.4B In Tow

    Boston-based private equity shop HarbourVest Partners, advised by Debevoise & Plimpton LLP, on Tuesday revealed that it closed its 13th U.S. flagship primary fund after securing $2.4 billion in total capital commitments.

  • April 21, 2026

    EQT Raises $15.6B For Asia-Pacific Private Equity Fund

    EQT AB said Tuesday that it has raised $15.6 billion for a fund that will give investors in the Swedish private equity firm access to technology and healthcare companies in the Asia-Pacific region.

  • April 20, 2026

    Armistice Head Testifies He Accidentally Deleted Texts

    Armistice Capital's founder, who is facing investor claims that the hedge fund dumped its artificially inflated shares in pharmaceutical company Vaxart for $250 million, told a California federal jury Monday that during a physical therapy session held over Skype, he accidentally deleted key text messages with another Armistice executive.

  • April 20, 2026

    SEC, CFTC Propose Rules To Relax Private Fund Reporting

    The U.S. Securities and Exchange Commission on Monday proposed relaxing certain reporting requirements for hedge funds and other private fund advisers by allowing smaller firms to forego filing a disclosure used to monitor systemic risk and nixing some of its questions around volatility, event reporting and indirect exposure altogether.

  • April 20, 2026

    Kirkland-Led Cerberus Closes $2.3B Continuation Fund

    Kirkland & Ellis LLP-advised Cerberus Capital Management on Monday announced that it closed its latest single-asset continuation vehicle after securing $2.3 billion in commitments, which will allow the private equity firm to continue to own a controlling stake in critical digital infrastructure company Subsea Communications.

  • April 20, 2026

    Catching Up With Delaware's Chancery Court

    The Delaware Chancery Court this past week delivered another mix of procedural rulings, fiduciary duty disputes and deal litigation, highlighting both the court's gatekeeping role and its continued focus on stockholder rights and transactional fairness.

  • April 20, 2026

    Justices Cast Doubt On Effort To Limit SEC Disgorgement

    The U.S. Supreme Court on Monday questioned an attempt to limit the U.S. Securities and Exchange Commission's disgorgement powers, with conservative and liberal justices alike seemingly skeptical of the argument that the agency has to identify victims before it can demand the return of ill-gotten gains.

  • April 20, 2026

    Kirkland, Goodwin Guide Lilly's Potential $7B Kelonia Buy

    Kirkland & Ellis LLP-advised pharmaceutical giant Eli Lilly & Co. on Monday announced plans to acquire clinical-stage biotechnology company Kelonia Therapeutics, led by Goodwin Procter LLP, in a deal worth up to $7 billion.

  • April 20, 2026

    4 Firms Guide $1.4B Honeywell, Brady Productivity Unit Deal

    Honeywell said Monday that it has agreed to sell its productivity solutions and services business to Brady Corp. as the company nears the completion of a multiyear portfolio transformation, with four law firms advising. 

  • April 20, 2026

    Justices Won't Review Vegas Hotel Algorithmic Pricing Suit

    The U.S. Supreme Court on Monday rejected a petition seeking to revive a proposed class action accusing casino-hotel operators on the Las Vegas Strip of using software from Cendyn Group to illegally inflate room rates.

  • April 17, 2026

    'Constantly Shifting': Judge Rips Musk, OpenAI As Trial Nears

    A California federal judge Friday appeared frustrated with Elon Musk and OpenAI ahead of trial over Musk's challenge to OpenAI's conversion to a for-profit entity, criticizing the parties' "constantly shifting" positions and doubting whether she has the authority to grant the relief Musk requested.

  • April 17, 2026

    Drone Co. Aevex Joins Defense-Related IPOs, Raising $320M

    Drone-maker Aevex Corp. began trading Friday after raising $320 million in its initial public ‌offering, steered by a Kirkland & Ellis LLP team and with Latham & Watkins LLP advising the underwriters.

  • April 17, 2026

    NorthStar Inks $300M SPAC Deal As Space Debris Risk Rises

    NorthStar Earth & Space said Friday it will merge with a blank-check company in a deal valuing NorthStar at $300 million, as the Canadian company bets that increasingly congested orbits will require continuous monitoring to avoid collisions and service disruptions.

  • April 17, 2026

    Macquarie Selling Romanian Grid Network For About $825M

    Premier Energy Group said Friday it has agreed to acquire Romania-based electricity distributor Distributie Energie Oltenia, or DEO, from funds managed by Australia's Macquarie Asset Management for about €700 million ($825 million).

  • April 17, 2026

    Reed Smith Lands McDermott Fund Finance Pro In Miami

    Reed Smith LLP has added a partner in Miami from McDermott Will & Schulte LLP to bolster its capacity to advise clients about fund finance and private capital matters.

  • April 17, 2026

    Latham Leads Kailera's $625M IPO In Obesity Drug Push

    Obesity biotech Kailera Therapeutics made its public debut Friday, raising $625 million in an upsized initial public offering that represents one of the largest biotech IPOs in recent years.

Expert Analysis

  • Chancery Exec Noncompete Ruling Offers PE Buyer Lessons

    Author Photo

    In Derge v. D&H United Fueling Solutions, the Delaware Court of Chancery sided with a private equity-backed portfolio company by enforcing a noncompete against an executive, providing private equity buyers with a checklist of factors for an enforceable noncompete in the sale-of-business context, says Danielle Asaad at Squire Patton.

  • Expect A New Normal In Commercial Real Estate This Year

    Author Photo

    Even amid office vacancies and a wave of loan maturities, the commercial real estate market isn't as volatile as one might expect heading into 2026, but market stress is still uniquely intersecting with broader business challenges, creating new opportunities for corporate counsel and other practitioners beyond real estate, says Mark Bell at Stinson.

  • Food Industry Braces For MAHA And Other Challenges In 2026

    Author Photo

    After the Make America Healthy Again movement kept the U.S. Food and Drug Administration under pressure in 2025, actions in the food safety space are likely to continue this year, including updated Supplemental Nutrition Assistance Program dietary guidelines and processed food definitions, say attorneys at Wiley.

  • Top 5 Antitrust Issues For In-House Counsel To Watch In 2026

    Author Photo

    With Trump administration enforcement policy having largely taken shape last year, antitrust issues that in-house counsel should have on the radar range from scrutiny of technology-assisted pricing to the return of merger remedies, say attorneys at Squire Patton.

  • 4 Developments That Defined The 2025 Ethics Landscape

    Author Photo

    The legal profession spent 2025 at the edge of its ethical comfort zone as courts, firms and regulators confronted how fast-moving technologies and new business models collide with long-standing professional duties, signaling that the profession is entering a period of sustained disruption that will continue into 2026, says Hilary Gerzhoy at HWG Law.

  • Navigating AI In The Legal Industry

    Author Photo

    As artificial intelligence becomes an increasingly integral part of legal practice, Law360 guest commentary this year examined evolving ethical obligations, how the plaintiffs bar is using AI to level the playing field against corporate defense teams, and the attendant risks of adoption.

  • How Fractional GCs Can Manage Risks Of Engagement

    Author Photo

    As more organizations eliminate their in-house legal departments in favor of outsourcing legal work, fractional general counsel roles offer practitioners an engaging and flexible way to practice at a high level, but they can also present legal, ethical and operational risks that must be proactively managed, say attorneys at Boies Schiller.

  • SEC Rulemaking Radar: A Reset, A Shift And A Preview Of '26

    Author Photo

    With major proposals withdrawn and new priorities emerging, forthcoming U.S. Securities and Exchange Commission proposals in 2026 will look to reshape how digital assets are regulated, recalibrate market structure and simplify how small companies go public, says Christopher Grobbel at Goodwin.

  • M&A Midmarket Shows Resilience Amid 2025 Challenges

    Author Photo

    Midmarket mergers and acquisitions showed a slight decline in volume but climbed in value for much of 2025, particularly in the private equity space, indicating that the middle market M&A environment is cautious but steady heading into 2026, say attorneys at Stoel Rives.

  • Del. Dispatch: Key 2025 Corporate Cases And Trends To Know

    Author Photo

    The Delaware corporate legal landscape saw notable changes in 2025, spurred by amendments to the Delaware General Corporation Law, ubiquitous artificial intelligence fervor, boardroom discussion around DExit, record shareholder activism activity and an arguably more expansive view of potential Caremark liability, say attorneys at Fried Frank.

  • Series

    Nature Photography Makes Me A Better Lawyer

    Author Photo

    Nature photography reminds me to focus on what is in front of me and to slow down to achieve success, and, in embracing the value of viewing situations through different lenses, offers skills transferable to the practice of law, says Brian Willett at Saul Ewing.

  • 2025 Brought A New Paradigm For Federal Banking Regulation

    Author Photo

    A series of thematic shifts defined banking regulation in 2025, including a fundamental reform of prudential supervision, a strategic easing of capital constraints, steps to streamline merger reviews, and a new framework for fair access and entrants seeking to offer banking services, say attorneys at Simpson Thacher.

  • Series

    Law School's Missed Lessons: Practical Problem Solving

    Author Photo

    Issue-spotting skills are well honed in law school, but practicing attorneys must also identify clients’ problems and true goals, and then be able to provide solutions, says Mary Kate Hogan at Quarles & Brady.

  • Learning From 2025 FCA Trends Targeting PE In Healthcare

    Author Photo

    False Claims Act enforcement trends and legislative developments from this year signal intensifying state and federal scrutiny of private equity's growing footprint in healthcare, and the urgency of compliance, says Lisa Re at Arnold & Porter.

  • Opinion

    A Uniform Federal Rule Would Curb Gen AI Missteps In Court

    Author Photo

    To address the patchwork of courts’ standing orders on generative artificial intelligence, curbing abuses and relieving the burden on judges, the federal judiciary should consider amending its civil procedure rules to require litigants to certify they’ve reviewed legal filings for accuracy, say attorneys at Shook Hardy.

Want to publish in Law360?


Submit an idea

Have a news tip?


Contact us here
Can't find the article you're looking for? Click here to search the Private Equity archive.